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Summary 
 
During the period 2009-2012 the total sales of antibiotics dropped by 51%, from 495 tonnes in 2009 to an 
estimated 244 tonnes in 2012 (FIDIN, 2012). This already exceeds the policy objective for 2013 set by the 
Dutch government, i.e., a 50% reduction in antibiotic use compared with 2009. Survey data on antibiotic 
use per animal species indicate a further decrease in all five livestock sectors examined in the first six 
months of 2012. 
 
Trends in total sales 
Based on semester of 2012 (1-1-2012 to 1-7-2012) the total sales of antibiotics in the veterinary sector in 
2012 are estimated to be 51% below the level of 2009. This means a decrease in the total sales of 
antibiotics, licensed for therapeutic use in animals in the Netherlands, from 495 tonnes in 2009 to an 
estimated 244 tonnes in 2012 (FIDIN, 2012). So the policy objective for 2013 - a 50% reduction compared 
with 2009 - may already be reached in 2012. 
 
Trends in use per species 
In 2012, as estimated based on the first semester, all five studied livestock sectors in the Netherlands 
showed a further decrease in antibiotic use. The trends over the last years are: 
­ sow/piglet farms: strong decrease, levelled off a bit in 2012; 
­ fattening pig farms: continuous strong decrease; 
­ broiler farms: strong decrease, levelled off a bit in 2012; 
­ veal calf farms: continuous substantial decrease; 
­ dairy farms: annual variation, strong decrease in 2012. 
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1 Introduction 
 
Aim 
The objective of this study is to obtain detailed insight into the trends in the exposure of farm animals to 
antibiotics. This is done by monitoring both overall sales data at the national level and usage data per 
animal species. The results of the study can be used by the Ministry of Economic Affairs, Agriculture and 
Innovation for policy evaluation. In addition, the usage data can play a role in interpreting trends in 
antimicrobial resistance. Moreover, these data might be used to inform the European Commission. 
 
Monitoring in the Netherlands 
Monitoring of antibiotic use in the Netherlands is done in three ways. First, FIDIN, the federation of the Dutch 
veterinary pharmaceutical industry, annually reports the overall sales of antibiotics. Second, LEI Wageningen 
UR monitors the antibiotic use per animal species, on a stratified sample of farms. Third, the large animal 
production sectors recently implemented centralised registration systems, monitoring the use on all farms. 
 
Monitoring in Europe 
All EU member states are required to monitor antimicrobial resistance in food-producing animals of public 
health concern (Zoonosis Directive 2003/99/EC). Within this context, monitoring of antibiotic use is equally 
important. Therefore the European Medicines Agency (EMA) is trying to establish national systems for the 
collection of data on sales of veterinary antimicrobial agents in Europe, in a standardised way (EMA, 2010). 
The sales data from FIDIN are also used for the national reporting to EMA. 
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2 Materials and methods 
 
2.1 Analysis of trends in total sales 
 
FIDIN reports the total amount of antibiotics (active ingredient in kilograms) sold in the Netherlands, at the 
level of pharmacotherapeutic groups. The data about use of active substances are based on sales data of 
members of FIDIN and are estimated to cover about 98% of all sales in the Netherlands. Actual 
consumption can differ from the amounts sold, as a result of stockpiling and cross-border use. The figures 
give information about the total sales for all animals, not per individual animal species. 
 The EMA collects harmonised data, primarily based on overall sales of veterinary antimicrobial agents. 
To ensure that the sales data provided by the EU member states are harmonised, an ESVAC Data Collection 
Protocol has been developed and a call for data has been sent to most EU member states.1 To fully 
implement the ESVAC protocol, FIDIN had to adjust the levels of active ingredients for several products, 
taking into account the salt and ester formulations and calculation factors of active ingredients expressed in 
international units. These corrections led to a reduction of the calculated total amount of active substance 
by approximately 4%. The sales figures as from 2010 were based on the ESVAC template; the figures of 
1999 to 2009 were re-calculated and corrected accordingly. 
 To adjust for trends in the size of the animal population the sales of antibiotics for therapeutic use were 
also expressed as grams of active ingredient per kilogram of live animal weight (Figure 3.1). For this 
purpose the FIDIN sales data were related to the total live weight of the average number of animals present 
in the Dutch livestock farming sector (pigs, poultry, veal calves, other cattle and sheep). For this analysis 
the following average weights were used: veal calves 172 kg (i.e. the weighted average of white veal calf 
164 kg and rosé veal calf 192 kg), other cattle 500 kg, turkeys 6 kg, other poultry 1 kg, fattening pigs 70 
kg, sows 220 kg, piglets (< 20 kg) 10 kg, sheep 60 kg. This yields information about the trend in the sales 
of therapeutic antibiotics in grams per kilogram of live animal weight present in the Netherlands over the 
years, consequently taking yearly fluctuations in the size of the animal population into account. 
 The yearly average numbers of animals and its conversion into live weight are given in Table A.1 and 
Table A.2 of the Appendix. For the estimate 2012 the 2011 numbers were used. 
 
2.2 Analysis of trends in use per species 
 
Daily doses (ADD) 
The use of different active ingredients measured in kilograms is not directly comparable due to their 
differences in antimicrobial potency, pharmacokinetics2, and, consequently, the dosage prescription. To 
provide insight into the true exposure of animals to antibiotics, the use should be determined per animal 
species and expressed in the number of Animal Daily Dose (ADD) per animal year (Jensen et al., 2004; 
abbreviated: 'dd per ay'). The ADD is the defined average maintenance dose of a specified medicine per kg 
of a specified animal per day, applied for its main indication. This unit conforms to international 
developments in this field and developments in the human health sector. With the ADD approach the 
calculation and comparison of the total antibiotic use on different farms is possible, even when different 
                                                   
1 EC Directive 2001/82/EC and Regulation 726/2004 form a legal basis for national authorities to request the pharmaceutical industry to 
provide data on sales of antimicrobial agents. Member states are not yet obliged to provide data about the use of veterinary antibiotics to the 
EC. 
2 Differences in dosage are determined by differences in potency, differences in bioavailability and distribution throughout the body. 
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active ingredients are involved. Expressing the use per animal year also enables comparisons of farms with 
different production and vacancy periods. 
 Furthermore, the ADD approach offers an opportunity to study the relationship between antibiotic use 
and the occurrence and trends in antimicrobial resistance. With an ADD approach also a comparison of 
countries could be possible, but only when based on reliable usage data per animal species. The now often 
reported difference in grams per kg of biomass, as calculated from national total sales figures, is 
reasonably suitable to adjust trends in the sales for changes in the size of the animal population within a 
country, but not for country comparisons. A comparison of countries based on overall averages is strongly 
influenced by animal demographics and therefore a very inaccurate indication of the true differences in 
antimicrobial exposure, per animal species. To get an appropriate certainty about the true differences 
between countries it is necessary to have reliable information about the use per animal species (Bondt et 
al., 2012). 
 
Calculating the number of daily dosages 
The use of different active ingredients becomes comparable when the amount of active ingredients in each 
antibiotic preparation is measured as the number of daily dosages. The number of daily dosages per animal 
year was determined by calculating the total number of kilograms of animal that can be treated with each 
active ingredient,3 the so-called treatable weight. This was then divided by the total weight of the average 
present livestock on the farm, assuming that the average treatment is administered to animals with an 
average weight.4 The following daily dosages box gives an example of the calculation of the number of daily 
dosages per animal year. 
 
Example: Calculation of the number of daily dosage  
For example, a farm with 150 fattening pigs with an average weight of 70.2 kg used 2 litres of antibiotic preparation X during the 
course of one year (X contains 40% = 400 mg/ml of active ingredient a) and 20 kg of antibiotic preparation Y (Y contains 25% = 250 
mg/g of active ingredient b). Antibiotic preparation X: the defined daily dosage of active ingredient a is 10 mg per kg of animal 
weight per day. Antibiotic preparation Y: the defined daily dosage of active ingredient b is 50 mg per kg of animal weight per day. 
 Antibiotic X can be used to treat (2,000 * 400)/10 = 80,000 kg of animal weight. Antibiotic Y can be used to treat (20,000 * 
250)/50 = 100,000 kg of animal weight. Consequently, the farm has used antibiotics for treatment of a total of 180,000 kg of 
animal weight. The farm has an average of 150 fattening pigs per year, with a total weight of 10,530 kg. 180,000 kg were treated in 
that year, equivalent to 180,000/10,530 = 17.1 daily dosages. Consequently, an average fattening pig5 on the farm in that year was 
administered a prescribed dosage of antibiotics on 17.1 days. In this example the farm uses 17.1 daily dosages per animal year of 
antibiotic preparation X plus Y. 
 
Animal weights 
The calculations in the sample survey are based on the average weight per animal during the animals' 
presence on the farm. The following average weights have been used: dairy cows 600 kg, veal calves 
                                                   
3 The use of antibiotics in spray containers is not included. 
4 The total weight is the average weight of the animals (in kg per animal) multiplied by the average number of animals present on the farm per 
year. Note that on dairy farms only the weight of the dairy cows has been taken into account. 
5 This refers to a pig on the farm throughout the year: however, there is no such pig. This is a method which can be used to provide for 
comparisons of farms with different vacancy rates. For example, a farm has 2 herds of animals a year, both of which comprise 200 animals 
that remain on the farm for 5.5 months. The farm is vacant during the first and last week of the year, and for 2 weeks between the two herds. 
The calculations for this farm are based on an average of 183 animals present on the farm. When a farm is vacant for six months and has a 
herd of 200 animals for six months, then the calculations are based on an average of 100 animals on the farm. 
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172 kg (i.e. the weighted average of white veal calf 164 kg and rosé veal calf 192 kg), broilers 1 kg, 
fattening pigs 70 kg, sows 220 kg, maiden gilts 107.5 kg, piglets (< 25 kg) 12.5 kg, breeding boars 350 
kg (ASG, 2010). On dairy farms the number of daily dosages is based on the weight of the dairy cows only, 
because this category of animals gets almost all of the antibiotics. On sow farms the size of the 'population 
at risk' is based on the weight of all present animals (including piglets, gilts, breeding boars). For an 
illustrative calculation of the number of daily dosages for young calves on dairy farms (from birth to weaning 
at 56 days of age) the average weight of 56.5 kg has been used. 
 
2.3 Survey data and statistical analysis 
 
Survey data 
This study uses survey data from farms in the Farm Accountancy Data Network (FADN) and additional veal 
calf farmers. The FADN contains a stratified sample of around 1,500 agricultural and horticultural farms in 
the Netherlands (Vrolijk et al., 2009). Records are made of the economic data and technical key figures of 
these farms. Every year a number of farms are replaced by other farms to ensure that the database of the 
Data Network remains representative of Dutch livestock farming. On these farms all animal-medicine data 
and veterinary services are recorded. This provides information about the true exposure of farm animals to 
antibiotics, and gives insight into the underlying factors that could explain changes in antibiotic use. In 
cooperation with the veal calf sector the use in veal calves is monitored in an additional random sample. On 
the veal calf farms detailed data were collected on the number of animals present and the amount of 
antibiotics used.  
 To ensure that the farms in the sample are representative of the whole population and to make the 
sampling as efficient as possible, a disproportional stratified random sampling strategy is used (Vrolijk et 
al., 2009). A stratified sample implies that the population is divided into a number of homogeneous groups. 
Subsequently, farms are selected from each of the groups. For strata with larger variation in the use of 
antibiotics, relatively more sample farms are selected. In the FADN sample the strata are based on both 
farm size and animal category. The additional sample of veal calf farms is additionally stratified for 'large 
integration' versus 'small integration or non-contracted farms'. 
 Data of 187 pig, broiler and dairy cattle farms in the FADN were used to estimate the antibiotic use in 
2012, based on the first semester. As from 2007, data from veal calf farms were collected in an additional 
sample. See Table 2.1 for details. More detailed data are available on the LEI website 
(www.wageningenUR.nl/en/lei) and the MARAN website (www.maran.wur.nl). 
 
 
 
LEI 12-109  Page 7 of 26 
 
Table 2.1 Number of sample farms taking part each year and the associated number of animals 
 Type of holding 2007 2008 2009 2010 2011 2012 a) 
Number of animals Sows/piglets 17,949 18,767 20,806 24,593 22,945 20,032 
 Fattening pigs 119,922 156,098 159,104 153,887 145,418 131,129 
 Broilers 2,197,716 2,508,103 2,530,313 2,244,706 2,245,689 1,768,678 
 Veal calves 124,115 134,437 134,446 124,634 119,746 82,194 
 Dairy cows 2,850 7,274 7,382 7,020 6,115 5,598 
Number of farms Sows/piglets 39 45 48 48 49 42 
 Fattening pigs 49 77 72 64 61 55 
 Broilers 29 29 28 25 26 22 
 Veal calves 185 199 193 173 162 113 
 Dairy cows 34 82 83 77 77 68 
 Total 336 432 424 387 375 300 
a) Number of sample farms in first semester of 2012. 
 
Statistical analysis 
Data from the FADN farms and the additional sample for veal calves are used to estimate the use in the 
whole population to obtain insight into the amount of and trends in antibiotic use on the national level. 
Antibiotic use per species on the national level is expressed as average number of daily dosages per 
average animal present on an average farm. Since the stratification is disproportional, the results have to 
be weighted to be representative. For each stratum the average daily dosages per animal year is 
determined. Then the weighted average for an animal category is calculated, based on the number of farms 
in the population in each stratum. 
 The aggregated usage data are considered to be representative for the total exposure of Dutch food-
producing animals to antibiotics. The 95% confidence intervals (CI) indicate that with 95% certainty, the 
average antibiotic use per animal on a national level, expressed by the number of daily dosages per animal 
year, will lie within the upper and lower limits given. The confidence interval also indicates the variation in 
antibiotic use amongst farms. 
 In this report the usage data of all sample farms are used for statistical analysis on not only antibiotic 
use in each year, but also on the changes in antibiotic use over a period of two or more years. Comparing 
average uses of antibiotics between two years can be done in two ways: one using only farms that are in 
the sample for both years,6 the other using all farms in the sample in both years. The first method usually 
gives better results if the majority of the farms are in the sample for both periods. This usually is the case in 
two consecutive years. However, if the years of comparison are further apart, the number of sample farms 
available in both years will be more limited. In that case, testing for significant differences can better be 
done by using all farms in the sample to increase the statistical power of the comparison.7 
 
 
  
                                                   
6 See Appendix 3 in Vrolijk et al. (2008) for more details about the statistics. 
7 If the difference between the two means is larger than twice the square root of the sum of both squares of the standard errors, then there is a 
significant difference. 
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3 Trends in total sales 
 
The total sales of antibiotics, licensed for therapeutic use in animals in the Netherlands, decreased from 
495 tonnes in 2009 to an estimated 244 tonnes in 2012, which is a decrease of 51% (FIDIN, 2012). This 
means that the policy objective for the year 2013 - a 50% reduction compared with 2009 - will probably 
already be reached in 2012. Almost all classes of antibiotics showed a decrease. 
 Figure 3.1 shows the trend in the total sales (in bars). The trend is also expressed in grams of active 
substance per kg of live weight present (line), to adjust for possible fluctuations in the size of the animal 
population.  
 
Figure 3.1 Therapeutic antibiotic sales, 1999-2012 a) 
  
a) Sales for 2012 are estimates, based on preliminary data of the first half year. 
Source: FIDIN (2012). 
 
Discussion 
The total sales volume amounted to an estimated 244 tonnes in 2012, which is substantially below the level 
of the year 1999. Moreover, at that time an additional 250 tonnes of antimicrobial growth promoters were 
used (see Table 3.1).  
 
Tetracyclines 
The sales data indicate a total decrease of 61% for tetracyclines in the period 2009-2012. The underlying 
detailed data show a stronger decrease of oxytetracyclines (67%) than of doxycyclines (49%). 
 
Fluoroquinolones 
In the first half year of 2012 the quinolones represented 1.3% of the total veterinary antibiotic sales in the 
Netherlands; the 'newer' fluoroquinolones represented 0.41% of the total sales (danofloxacin, difloxacin, 
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enrofloxacin and marbofloxacin). In the period 2009-2012 the sales of quinolones decreased by 59%; the 
newer fluoroquinolones showed a decrease of 23%. 
 
Cephalosporins 
In the first half year of 2012 the cephalosporins represented 0.10% of the total sales. In the period 2009-
2012 the estimated sales of third- and fourth-generation cephalosporins (cefoperazon, cefovecin, 
cefquinome, ceftiofur, cefuroxim) showed an enormous decrease of 92%, to 0.03% of the total sales. 
 
Table 3.1 Antibiotic sales in tonnes, 1999-2012 a) 
 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
Penicillins/cephalosporins 35 36 38 38 36 43 51 57 61 70 73 71 66 56 
Tetracyclines 162 194 200 214 216 256 292 301 321 257 251 217 157 99 
Macrolides 10 15 17 19 17 23 28 42 55 52 46 39 34 32 
Aminoglycosides 13 12 11 10 9 9 11 11 12 11 10 9 7 6 
Fluoroquinolones 7 7 6 6 5 7 8 7 9 8 8 7 5 3 
Trimethoprim/Sulfonamides 72 80 92 92 88 91 91 93 99 100 92 78 58 45 
Others 11 12 11 11 7 6 6 8 8 7 15 13 10 3 
Total therapeutic sales 310 356 376 390 378 434 487 519 565 506 495 433 338 244 
Gram therapeutic per kg live 
weight 
0.11 0.14 0.15 0.16 0.15 0.18 0.20 0.22 0.23 0.20 0.19 0.17 0.13 0.10 
Antimicrobial growth promoters 
(AGP) 
250 205 180 140 120 80 40 0 0 0 0 0 0 0 
Total sales including AGP 560 561 556 530 498 514 527 519 565 506 495 433 338 244 
 Sales for 2012 are estimates, based on preliminary data of the first half year. 
Source: FIDIN (2012).  
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4 Trends in use per species 
 
As shown in Figure 4.1, sample surveys reveal the following tendencies for the years 2009 to the first half 
year of 2012, indicating a further decrease in antibiotic use in all five studied livestock sectors in the 
Netherlands in 2012, when extrapolated to annual usage. The sample surveys indicate a decrease in all 
livestock sectors in the Netherlands in 2012. The usage data in Figure 4.1 are indexed, using 2009 as 
baseline year. The continuous line represents the estimated average use. The 95% confidence intervals are 
indicated by the dotted lines. In the paragraphs per livestock sector the results are presented from 2004 to 
2012.  
 
Figure 4.1 Trends in antibiotic use per species, 2009-2012 a) 
 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
 Figure 4.1 shows the tendencies in antibiotic use per animal species from 2009 to 2012, indicating a 
further decrease in all studied livestock sectors in the Netherlands in 2012. The trends over the last years 
are: 
­ sow/piglet farms: strong decrease, levelled off a bit in 2012; 
­ fattening pig farms: continuous strong decrease; 
­ broiler farms: strong decrease, levelled off a bit in 2012; 
­ veal calf farms: continuous substantial decrease; 
­ dairy farms: annual variation, strong decrease in 2012. 
 
 For all livestock sectors the decrease in the period 2009-2012 was statistically significant. 
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 Note that the exposure in 2012 is an estimate based on preliminary data of the first half year. Final 
figures about the antibiotic usage in the whole year 2012 may differ from this estimate, because of the 
following factors: 
­ analysis of more sample farms: the estimate is based on approximately 80% of the sample farms; 
­ structural seasonal effects: there might be seasonal differences in usage due to different weather 
conditions in winter, spring and early summer compared with autumn and early winter; 
­ incidents: antibiotic usage will be lower in case of no outbreaks of diseases or extreme beneficial 
weather conditions, and vice versa; 
­ normal stocks of veterinary medicines: the same stock has an higher impact on a half-year estimate 
compared with a year estimate. 
 
 Except for the first comment, the comments above also hold for the total sales data. 
 In the following paragraphs the use of the different types of antibiotics per livestock species is 
addressed in detail. 
 
4.1 Pigs 
 
Sows and piglets 
Figure 4.2 shows the trend in antibiotic use from 2004 to 2012: annual variation, with a strong decrease as 
from 2009, which seems to level off a bit in 2012. 
 
Figure 4.2 Trend in antibiotic use in sows/piglets, 2004-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
 Based on the first semester, the average use in sows/piglets is estimated to be 10 daily dosages per 
year in 2012 (95% Confidence Interval: 8-13 dd/ay). In 2009 the use was 25 daily dosages per year (95% 
CI: 21-30 dd/ay). The large confidence intervals are mainly caused by the large variation in use that exists 
between different farms. Seventy-five per cent of the antibiotics were orally administered, probably 
predominantly in piglets.  
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 Figure 4.3 provides insight into the trends in the relative use of the various groups of antibiotics.  
 
Figure 4.3 Antibiotic use in sows/piglets in dd per sow per year, 2004-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
 In 2012 31% of the total antibiotic use in sows/piglets consisted of tetracyclines, 36% of penicillins and 
another 17% of trimethoprim/sulfonamides. 
 Figure 4.4 shows the trends in the use of the antimicrobial classes defined as the most critically 
important in human medicine by the World Health Organization i.e. third- and fourth-generation 
cephalosporins, fluoroquinolones and macrolides. An important finding is that since 2009 the use of 
macrolides decreased substantially, and that in 2012 both the use of third- and fourth-generation 
cephalosporins and the use of fluoroquinolones in sows/piglets has dropped to zero.  
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Figure 4.4 Antibiotic use in sows/piglets in dd per sow per year, 2004-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
Discussion 
Within the sample, about 57% of the farms had an antibiotic use within the target level ('streefniveau') for 
2012 of the Animal Drug Authority (SDa, 2012), 29% within the signalling level ('signaleringsniveau'), and 
14% within the action level ('actieniveau').  
 In 2012, the use in sows/piglets was 10 daily dosages per animal year. However, in practice most 
antibiotics are likely used for the treatment of the piglets, and only incidentally for the sows. If it is assumed 
that 100% of the antibiotics are administered to the piglets, which have an average weight of 12.5 kg, this 
would mean that an average piglet is treated with antibiotics during 10 days in the period from birth to the 
age of 74 days (when the piglet weighs 25 kg and is delivered to the fattening farm). 
 
Fattening pigs 
Figure 4.5 shows the trend in antibiotic use from 2004 to 2012: increase until 2008, strong decrease from 
2008 to 2012. 
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Figure 4.5 Trend in antibiotic use in fattening pigs, 2004-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
 Based on the first semester, the average use in fattening pigs is estimated to be less than 6 daily 
dosages per year in 2012, of which 90% are orally administered (95% Confidence Interval: 4-7 dd/ay). In 
2009 the average use was 16 daily dosages per year (CI: 11-20 dd/ay).  
 Figure 4.6 provides insight into the trends in the relative use of the various groups of antibiotics. 
 
Figure 4.6 Antibiotic use in fattening pigs in dd per animal year, 2004-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
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 In 2012, 74% of the total antibiotic use in fattening pigs originated from the administration of 
tetracyclines and 10% from macrolides/lincosamides. 
 Figure 4.7 shows the trends in the use of the antimicrobial classes defined as the most critically 
important in human medicine by the World Health Organization, i.e. third- and fourth-generation 
cephalosporins, fluoroquinolones and macrolides. An important finding is that since 2009 the use of 
macrolides dropped substantially, and that in 2012 both third- and fourth-generation cephalosporins and 
fluoroquinolones were no longer applied. 
 
Figure 4.7 Antibiotic use in fattening pigs in dd per animal year, 2004-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
Discussion 
Within the sample about 69% of the farms had an antibiotic use within the target level ('streefniveau') for 
2012 of the Animal Drug Authority (SDa, 2012), 11% within the signalling level ('signaleringsniveau'), and 
20% fall into the action level ('actieniveau').  
 In 2012, the use in fattening pigs was approximately 6 daily dosages per animal year. Assuming a 
production period of 117 days, 2 daily dosages (= 6 x (117/365) are administered to each fattening pig 
during its production period from 25 kg to slaughter weight. This fattening pig has also received antibiotics 
at the breeding farm (during a maximum of 10 days), which brings the total exposure to antibiotics per 
fattening pig to approximately 12 days during its whole life from birth to slaughter at the age of 191 days. 
 If it is assumed that the average treatment weight of fattening pigs will be 30% lower than their average 
live weight - since younger animals are more likely to receive antibiotics than older animals - the estimation 
of the true exposure during the total lifetime increases from 12 days to a total of 13 days. Compared with 
2009 this is a decrease of the total exposure of approximately 60%. 
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4.2 Broilers 
Figure 4.8 shows the trend in antibiotic use from 2004 to 2012: an increase until 2008, and a strong 
decrease from 2009 to 2012, which seems to level off a bit in 2012. 
 
Figure 4.8 Trend in antibiotic use in broilers, 2004-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
 Based on the first semester, the average use in broilers is estimated to be 14 daily dosages per year in 
2012, administered orally, mainly through the drinking water (95% Confidence Interval: 9-20 dd/ay). In 
2009 the use was 37 daily dosages per year (CI: 24-49 dd/ay). 
 Figure 4.9 provides insight into the trends in the relative use of the various groups of antibiotics. 
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Figure 4.9 Antibiotic use in broilers in dd per animal year, 2004-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
 In 2012, the administration of penicillines accounted for 38% of the total antibiotic use on broiler farms, 
quinolones for 22%, intestinal anti-infectives for 15 % and tetracyclines for 8%. The use of intestinal anti-
infectives (e.g. orally administered neomycin, colistin) decreased from 7 dd/ay in 2009 to 2 dd/ay in 2012. 
 Figure 4.10 shows the trends in the use of the antimicrobial classes defined as the most critically 
important in human medicine by the World Health Organization i.e. third- and fourth-generation 
cephalosporins, fluoroquinolones and macrolides. The use of macrolides and fluoroquinolones varies, and is 
at a relatively low level in 2012. In this year, 2.7% of the total use consisted of fluoroquinolones and 2.2% 
of macrolides/lincosamides. Cephalosporins were not applied. 
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Figure 4.10 Antibiotic use in broilers in dd per animal year, 2004-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
Discussion 
Within the sample about 64% of the farms had an antibiotic use within the target level ('streefniveau') for 
2012 of the Animal Drug Authority (SDa, 2012), 23% within the signalling level ('signaleringsniveau'), and 
13% within the action level ('actieniveau').  
 In 2012, the use was 14 daily dosages per animal year. This means that an individual broiler is treated 
with antibiotics during 1.6 days (= 14 x 42/365) in the 42 days from day one to slaughter. 
 Data on the time of prescription reveal that the average weight at which broilers receive treatment 
equals the average live weight of 1.0 kg. Therefore the calculated exposure of approximately 1.6 days per 
broiler can be considered as a reasonably adequate estimation of the true exposure (i.e. 1 to 2 treatment 
days per broiler, considering the 95% confidence interval). 
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4.3 Veal calves 
Figure 4.11 shows the trend in antibiotic use in veal calves: a substantial decrease from 2007 to 2012. 
 
Figure 4.11 Trends in antibiotic use in veal calves, 2007-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
 Based on the first semester, the average use in veal calves is estimated to be 21 daily dosages per 
animal year in 2012, of which 88% was orally administered (95% Confidence Interval: 20-23 dd/ay). In 2009 
the average use was 30 daily dosages per animal year (CI: 28-31 dd/ay). The reduction in the period 2009-
2012 is almost 30%. The total reduction in 2012 is 37%, compared with the start of the monitoring in veal 
calves in 2007. In 2007 the average use was 34 daily dosages per animal year. 
 Figure 4.12 provides insight into the trends in the relative use of the various groups of antibiotics. 
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Figure 4.12 Antibiotic use in veal calves in dd per animal year, 2007-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
 In 2012, 49% of the total antibiotic use on the veal calf farms originated from the administration of 
tetracyclines, 13% from macrolides/lincosamides, 10% from intestinal anti-infectives (e.g. neomycin, 
colistin) and 9% from trimethoprim/sulfonamides. 
 Figure 4.13 shows the trends in the use of the antimicrobial classes defined as the most critically 
important in human medicine by the World Health Organization i.e. third- and fourth-generation 
cephalosporins, fluoroquinolones and macrolides. The use of fluoroquinolones varies annually, with 1.9% of 
the total use in 2012. The use of third- and fourth-generation cephalosporins in veal calves decreased to 
almost zero (0.1%). 
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Figure 4.13 Antibiotic use in veal calves in dd per animal year, 2007-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
Discussion 
Within the sample 31% of the veal calf farms had a use level within the target level ('streefniveau') for 2012 
of the Animal Drug Authority (SDa, 2012), 50% within the signalling level ('signaleringsniveau'), and 19% 
within the action level ('actieniveau'). 
 The overall use further decreased, mainly as a result of less use of traditional antibiotic therapy with 
tetracyclines. In 2012, 21 daily dosages of antibiotics were administered per animal year. This means that 
the individual average veal calf was treated with antibiotics during 13 days (= 21 x 222/365) in the period 
from birth (or more precisely: from arrival at the veal calf farm) to the average slaughter age of 222 days 
(white and rosé). 
 If it is assumed that the average treatment weight of veal calves is about 50% lower than the average 
live weight, since younger animals are more likely to receive antibiotics than older animals, the estimation of 
the true exposure during the total lifetime increases from 13 days to a total of 26 days. 
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4.4 Dairy cows 
Figure 4.14 shows the trend in antibiotic use from 2004 to 2012: annual variation, strong decrease in 
2012. 
 
Figure 4.14 Trends in antibiotic use in dairy cows, 2004-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
 Based on the first semester, the average use in dairy cows is estimated to be 4.2 daily dosages per 
year in 2012, including the use in young stock (95% Confidence Interval: 3.6-4.9 dd/ay). In 2009 the use 
was 5.8 daily dosages per year (CI: 5.1-6.5 dd/ay). 
 Figure 4.15 provides insight into the trends in the relative use of the various groups of antibiotics. 
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Figure 4.15 Antibiotic use in dairy cows in dd per animal year, 2004-2012 a) 
 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
 In 2012, 48% of the total antibiotic use on dairy farms originated from the administration of penicillins 
and 32% from combinations, which were mainly applications for intramammary treatment.  
 Figure 4.16 shows the trends in the use of the antimicrobial classes defined as the most critically 
important in human medicine by the World Health Organization, i.e. third- and fourth-generation 
cephalosporins, fluoroquinolones and macrolides. The use of third- and fourth-generation cephalosporins 
dropped from 13% in 2009 to almost zero (1%) in 2012. Furthermore, the use of fluoroquinolones in dairy 
cows showed a substantial decrease in 2009-2012 from 1.4% to 0.2%. 
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Figure 4.16 Antibiotic use in dairy cows in dd per animal year, 2004-2012 a) 
 
a) Results for 2012 are estimates, based on preliminary data of the first half year. 
 
Discussion 
Within the sample about 62% of the farms had an antibiotic use within the target level ('streefniveau') for 
2012 of the Animal Drug Authority (SDa, 2012), 29% between target value and signalling value, 7% above 
the signalling value ('signaleringswaarde'), and only one farm (less than 2%) above the action level 
('actiewaarde').  
 In 2012 4.2 daily dosages of antibiotics were administered per animal year, of which 0.06 for oral use. 
If it is assumed that the oral use is only applied in young calves, an average calf is exposed to antibiotics 
during 2 days of the 56-day weaning period.  
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